1-3 of 3
Luca Fumagalli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy

Anna Guidetti, MD, Giulia Perrone, MD, Paola Coluccia, MD, Luca Fumagalli, MD, Anna Dodero, MD, Lucia Farina, MD, Flavio Arienti, MD, Filippo Bagnoli, MD, Luca Pappalettera, MD, Debora Degli Innocenti, Cristiana Carniti, PhD, Daniela Codazzi, MD, Paolo Corradini
Journal: Blood
Blood (2019) 134 (Supplement_1): 5619.
https://doi.org/10.1182/blood-2019-125286
Published: 2019
Journal Articles

Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial

Andrés J M Ferreri, MD, Michele Spina, Chiara Cattaneo, MD, Luisa Verga, MD, Bernardino Allione, Daris Ferrari, Luigi Rigacci, Luca Fumagalli, MD, Giovanni Donadoni, MD, Arben Lleshi, MD, Marianna Sassone, MD, Giuseppe Rossi, MD, Alessandro Re, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2828.
https://doi.org/10.1182/blood.V130.Suppl_1.2828.2828
Published: 2017
Journal Articles

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

Marta Bruno Ventre, MD, Giovanni Donadoni, MD, Alessandro Re, MD, Michele Spina, MD, Chiara Cattaneo, Luca Fumagalli, MD, Silvia Mappa, MD, Silvia Govi, MD, Giuseppe Rossi, MD, Umberto Tirelli, MD, Andrés JM Ferreri, MD
Journal: Blood
Blood (2011) 118 (21): 2692.
https://doi.org/10.1182/blood.V118.21.2692.2692
Published: 2011